Concepedia

Kirsteen Donaldson

KD

Statistics

Publications

13

Citations

408

H-Index

12

Active since

1979

Affiliations

Cambridge Consultants (United Kingdom)(Current)

Corcept Therapeutics (United States)

University of Southampton

Quotient Clinical (United Kingdom)

21c Consultancy (United Kingdom)

Kirsteen Donaldson is an author at Cambridge Consultants (United Kingdom) specializing in medicine, pharmacology, and clinical pharmacology.

Publications per year

1979–2021

13

Publications

13

Linezolid, a Novel Oxazolidinone Antibiotic: Assessment of Monoamine Oxidase Inhibition Using Pressor Response to Oral Tyramine

Edward J. Antal, Pamela E. Hendershot, Donald H. Batts et al. · The Journal of Clinical Pharmacology · 2001 · 66 citations

Medicine, Pharmacokinetics, Pharmacology +13

Assessment of Safety, Tolerability, Pharmacokinetics, and Pharmacological Effect of Orally Administered CORT125134: An Adaptive, Double‐Blind, Randomized, Placebo‐Controlled Phase 1 Clinical Study

Hazel Hunt, Kirsteen Donaldson, Mark Strem et al. · Clinical Pharmacology in Drug Development · 2017 · 63 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +9

FIBRE AND DIABETES

DavidJ.A. Jenkins, R. Nineham, Charles Craddock et al. · The Lancet · 1979 · 52 citations

Safety, Tolerability and Pharmacokinetics of FAAH Inhibitor V158866: A Double-Blind, Randomised, Placebo-Controlled Phase I Study in Healthy Volunteers

Stephen Pawsey, Mike Wood, Helen Browne et al. · Drugs in R&D · 2016 · 50 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +11

Elinzanetant (NT-814), a Neurokinin 1,3 Receptor Antagonist, Reduces Estradiol and Progesterone in Healthy Women

Steve Pawsey, Edouard Gregory Mills, Elizabeth Ballantyne et al. · The Journal of Clinical Endocrinology & Metabolism · 2021 · 32 citations · Full text

Medicine, Endocrinology, Pharmacology +17

1–5 of 13